The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCirata Regulatory News (CRTA)

Share Price Information for Cirata (CRTA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.50
Bid: 50.10
Ask: 51.90
Change: 2.50 (5.00%)
Spread: 1.80 (3.593%)
Open: 50.80
High: 52.50
Low: 50.80
Prev. Close: 50.00
CRTA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

17 Nov 2023 17:54

RNS Number : 8948T
Cirata PLC
17 November 2023

[17] November 2023

Cirata plc

("Cirata" or the "Company")

Director/PDMR Shareholdings

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Cirata plc (LSE: CRTA) provides the following notification of a transaction by persons discharging managerial responsibilities ("PDMR").

On 17 November 2023, Mr Stephen Kelly, Chief Executive Officer, purchased 248,600 Ordinary Shares in Cirata at a price of 48 pence per Ordinary Share. Following this purchase and on completion of the Allotment Award share matching transaction, Mr Stephen Kelly will be the beneficial owner of 2,032,600 Ordinary Shares representing approximately 1.76% of the Company's "when issued" share capital.

The total beneficial shareholding of 2,032,600 Ordinary Shares is comprised of open market purchases by Mr Stephen Kelly totalling 1,182,680 Ordinary Shares, plus the company's share Allotment Award of 850,000[1] Ordinary Shares, giving a total beneficial ownership post allotment of 2,032,600 Ordinary Shares.

The following represents the Director dealing

Buying PMDR

Ordinary shares purchased

Price of Ordinary Shares acquired, 17 November 2023

Total beneficial interest post purchase

Mr Stephen Kelly, CEO

248,600

48 pence

1,182,680

The following represents the Directors beneficial interest post the "Allotment Award" Shares

Transaction

Shares / %

Shareholding as of COB 16 Nov 23

1,182,680

Allotment Award Shares

850,000

Total beneficial Interest post Allotment Award

2,032,680

% beneficial Ordinary Share ownership post Allotment Award

1.76%

"Allotment Award"/Allotment Award Shares"

As previously disclosed on 3 July "Launch of Fund Fundraise" under the terms of Mr Stephen Kelly's service agreement, the Company has agreed (up to a capped limit) that during the 12-month period from the commencement of service, for every Ordinary Share purchased by Mr Stephen Kelly in the open market the Company will issue and allot on a 1-1 basis a match to this purchase. This shall be limited to a maximum value of 1 times £425,000 (based on the price per Ordinary Share paid) (the "Allotment Award Shares").

The number of shares purchased by Mr Stephen Kelly that are eligible for a match have exceeded the capped limit of £425,000 (The book value of open market purchases to date is approximately £545,000). As a result, under the terms of the Allotment Award, Mr Stephen Kelly will be issued a further 850,000 Ordinary Shares. The Allotment Award Shares will be issued by the financial year end 2023.[2]

The Notification of Dealing Form for this transaction is included at the end of this announcement.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

This announcement contains information that qualifies or may qualify as inside information. The person responsible for arranging the release of this announcement on behalf of Cirata plc is Larry Webster, Company Secretary.

Cirata plc

Via FTI Consulting

Stephen Kelly, Chief Executive Officer

Ijoma Maluza, Chief Financial Officer

Daniel Hayes, Investor Relations

FTI Consulting

+44 (0)20 3727 1137

Matt Dixon / Kwaku Aning / Usama Ali

Stifel (Nomad and Joint Broker)

+44 (0)20 7710 7600

Fred Walsh / Richard Short / Tom Marsh

Liberum (Joint Broker)

+44 (0)20 3100 2000

Max Jones / Ben Cryer / Miquela Bezuidenhoudt

About Cirata

Cirata accelerates data-driven revenue growth by automating data transfer and integration to modern cloud analytics and AI platforms without downtime or disruption. With Cirata, data leaders can leverage the power of AI and analytics across their entire enterprise data estate to freely choose analytics technologies, avoid vendor, platform, or cloud lock-in while making AI and analytics faster, cheaper, and more flexible. Cirata's portfolio of products and technology solutions make strategic adoption of modern data analytics efficient and automated. For more information about Cirata, visit www.cirata.com

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Stephen Kelly

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cirata plc

b)

LEI

213800Y1A75RSC698O04

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares 10 p each

ISIN: JE00B6Y3DV84

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

48 pence

248,600

d)

Aggregated information

- Aggregated volume

- Price

248,600

48 pence

e)

Date of the transaction

17 October 2023

f)

Place of the transaction

London Stock Exchange (XLON)


[1] The number of shares allocated (850,00) is derived by taking the agreed value cap of £425,000 and dividing by the purchase price per share (50 pence per share) of Mr Stephen Kelly's open market trades.

[2] The Company's issued share capital at 1 November 2023 consisted of 114,898,711 ordinary shares of ten pence each with voting rights admitted to trading. The Company holds no ordinary shares in Treasury. Upon completion of the Allotment Share Awards the issued share capital will increase by 850,000 shares leading to a total of 115,748,711 issued share capital.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBRBDBXUBDGXR
Date   Source Headline
29th Apr 20245:01 pmRNSFurther re: Annual Report & Notice of AGM
24th Apr 20247:00 amRNSDirectorate Change
17th Apr 20243:05 pmRNSAnnual Report & Notice of AGM
9th Apr 20247:00 amRNSQ1 FY24 Trading Update
4th Apr 20247:00 amRNSFinal Results
6th Mar 20245:19 pmRNSHolding(s) in Company
4th Mar 20242:53 pmRNSHolding(s) in Company
21st Feb 20241:27 pmRNSHolding(s) in Company
15th Feb 20244:27 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSChair appointment
9th Jan 20247:00 amRNSTrading Update
4th Jan 20243:10 pmRNSTotal Voting Rights
4th Jan 20242:41 pmRNSHolding(s) in Company
3rd Jan 20245:40 pmRNSHolding(s) in Company
2nd Jan 20249:32 amRNSNotice of Q4 FY23 Trading Update
14th Dec 20236:12 pmRNSBlock Listing Application
12th Dec 20235:32 pmRNSGrant of Share Options to PDMRs
12th Dec 20238:29 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSTotal Voting Rights
5th Dec 202310:25 amRNSHolding(s) in Company
24th Nov 20235:40 pmRNSDirector/PDMR Shareholding
23rd Nov 202310:08 amRNSHolding(s) in Company
21st Nov 20235:41 pmRNSHolding(s) in Company
21st Nov 20231:28 pmRNSHolding(s) in Company
21st Nov 20237:00 amRNSDirector/PDMR Shareholding
17th Nov 20235:54 pmRNSDirector/PDMR Shareholding
8th Nov 20231:18 pmRNSHolding(s) in Company
7th Nov 20232:39 pmRNSTotal Voting Rights
2nd Nov 20237:00 amRNSChange of Auditor
27th Oct 20235:12 pmRNSHolding(s) in Company
18th Oct 20237:00 amRNSTrading Update and Outlook
6th Oct 202312:12 pmRNSHCSC renews contract
6th Oct 202311:24 amRNSHolding(s) in Company
5th Oct 202310:39 amRNSNotice of Q3 FY23 Trading Update
5th Oct 20239:00 amRNSNatWest expands contract
5th Oct 20237:00 amRNSConfirmation of Ticker Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.